Deb Kelly, professor of biomedical engineering, Huck Chair in Molecular Biophysics and director of the Penn State Center for Structural Oncology, and her research team were recently highlighted by the Royal Society of Chemistry with this infographic representing their research. Credit: Royal Society of Chemistry, Nanoscale
Penn State biomedical engineer’s work highlighted by international society
2/4/2022
UNIVERSITY PARK, Pa. — Deb Kelly, professor of biomedical engineering, Huck Chair in Molecular Biophysics and director of the Penn State Center for Structural Oncology, recently had her research highlighted by the Royal Society of Chemistry. Kelly’s work on visualizing the antibody-binding site of the Nucleocapsid (N) protein — the protein that COVID-19 antigen tests detects — in SARS-CoV-2 was featured in an infographic created by the society’s scientific journal, Nanoscale. The infographic represents Kelly’s novel approach to uncover the first full structure of the N protein that led to her and her team discovering how antibodies from COVID-19 patients interact with the protein. They found that the structure is similar across coronaviruses, including COVID-19 variants — making it a target for advanced treatments and vaccines.
Share this story:
